Delynov Chirurgie, Delynov Aortopulmonary window closure and mitral valve repair in a 7-month-old infant Aortopulmonary window (APW) is a rare cardiovascular malformation, accounting for only 0.1 to 0.2% of congenital heart diseases. Characterized by a communication ... Jul 21, 2026
Delynov Chirurgie, Delynov T-TEER vs Annuloplasty: Edge-to-Edge More Effective for Tricuspid Regurgitation The management of severe symptomatic secondary tricuspid regurgitation (TR) has been transformed by the advent of percutaneous technologies. While edge-to-edge repair (... Jul 21, 2026
Delynov Chirurgie, Delynov Fragmented QRS: a warning sign for the left ventricle after mitral surgery In chronic mitral regurgitation surgery, a preserved preoperative left ventricular ejection fraction (LVEF) may mask actual myocardial vulnerability. P... Jul 9, 2026
Delynov Chirurgie, Delynov Mitral Regurgitation: Robotics or Transcatheter, Which Choice in 2025? Mitral regurgitation (MR) is now emerging as an endemic valvular pathology, driven by an ageing population and the rise in cardiac comorbidities. Jul 9, 2026
Delynov Chirurgie, Delynov Pediatric mitral valve repair: the value of global strain for follow-up Mitral valve disease remains rare in children, but its management requires critical surgical decision-making. While prosthetic replacement is an option, it exposes... Jul 8, 2026
Delynov Chirurgie, Delynov Adult Ebstein’s Anomaly: 3D Endoscopic Tricuspid Valve Repair Surgical treatment of Ebstein's anomaly in adults traditionally relies on cone reconstruction or classic ventricular plication. However... Jul 3, 2026
Delynov Chirurgie, Delynov DOACs vs VKAs after heart valve surgery: stroke depends on valve type Anticoagulation management in patients with atrial fibrillation (AF) following left-sided bioprosthetic valve replacement or mitral repair remains a clinical challenge. Jul 1, 2026
Delynov Chirurgie, Delynov Mitral endocarditis: 4.2% early mortality in minimally invasive approach Infective endocarditis (IE) of the mitral valve remains a formidable pathology, with hospital mortality rates ranging from 17% to 33%. While median sternotomy (ST) remains the... Jun 29, 2026
Delynov Chirurgie, Delynov Respect or Resect in mitral valve repair: identical durability at 5 years Mitral valve repair (MVr) is established as the therapeutic standard for degenerative mitral regurgitation (DMR), superseding valve replacement due to superior clinical outcomes. Jun 29, 2026
Delynov Chirurgie, Delynov Barlow Disease: 88% survival at 8 years after minimally invasive mitral valve repair Barlow disease (BD) represents one of the most complex forms of mitral degeneration, characterized by excessive valvular tissue, annular dilatation and pro... Jun 29, 2026
Delynov Chirurgie, Delynov Situs inversus: the challenge of totally endoscopic 3D mitral valve repair Situs Inversus Totalis (SIT) with mirror-image dextrocardia (MID) imposes major anatomical constraints on minimally invasive mitral valve surgery. Beyond access... Jun 22, 2026
Delynov Chirurgie, Delynov Tricuspid Regurgitation: What is the impact of TTVR treatment on sympathetic stress? Sympathetic nervous system (SNS) hyperactivity represents a major pathophysiological pivot in numerous cardiovascular conditions, particularly heart failur... Jun 19, 2026